CRA consultants assessed whether disputed representations of bioequivalence significantly affected sales of the branded product. The evaluation included consideration of distribution channels, purchase timing, and the effect of payor control mechanisms on product uptake and sales. The case ultimately resulted in a settlement.
Dr. Alison Hole joins CRA's Antitrust & Competition Economics Practice
CRA is pleased to announce that Dr. Alison Hole has joined the company as a Vice President in the Antitrust & Competition Economics Practice.